• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

2seventy bio, Inc. - Common Stock (NQ:TSVT)

5.000 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.000
Bid (Size) 4.990 (1,322)
Ask (Size) 5.000 (20)
Prev. Close 5.000
Today's Range 5.000 - 5.000
52wk Range 2.290 - 5.300
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2seventy bio Reports First Quarter Financial Results and Provides Update on Proposed Acquisition by Bristol Myers Squibb
May 07, 2025
From 2seventy bio, Inc.
Via Business Wire
2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT
April 16, 2025
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
+68.9%
+68.9%
1 Month
N/A
N/A
3 Month
+0.2%
+0.2%
6 Month
+98.4%
+98.4%
1 Year
+9.3%
+9.3%

More News

Read More
2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results
March 25, 2025
From 2seventy bio, Inc.
Via Business Wire
Earnings Scheduled For November 12, 2024
November 12, 2024
Via Benzinga
2seventy bio Earnings Preview
November 11, 2024
Via Benzinga
2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT
March 14, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
Unusual volume stocks are being observed in Wednesday's session.
March 12, 2025
Via Chartmill
Shareholder Alert: The Ademi Firm investigates whether 2seventy bio, Inc. is obtaining a Fair Price for its Public Shareholders
March 11, 2025
From Ademi & Fruchter LLP
Via Business Wire
Tuesday's session: top gainers and losers
March 11, 2025
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 2seventy bio, Inc. (Nasdaq - TSVT), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Chimerix, Inc. (Nasdaq - CMRX), 180 Degree Capital Corp. (Nasdaq – TURN)
March 11, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
Gapping stocks in Tuesday's session
March 11, 2025
Via Chartmill
Crude Oil Gains 1%; Ciena Earnings Top Views
March 11, 2025
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
March 11, 2025
Via Chartmill
Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal
March 11, 2025
Via Benzinga
US Stocks Mixed; Kohl's Shares Plunge After Q4 Results
March 11, 2025
Via Benzinga
This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
March 11, 2025
Via Benzinga
Top 3 Health Care Stocks That May Keep You Up At Night In Q1
March 11, 2025
Via Benzinga
TSVT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 2seventy bio, Inc. Is Fair to Shareholders
March 11, 2025
From Halper Sadeh LLC
Via Business Wire
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
March 11, 2025
Via Benzinga
US Stocks Likely To Open Higher After Monday's Selloff: TSLA Stock Rebounds From Its Worst Fall In 5 Years After Trump Backs Musk, Analyst Says 'Pullbacks Are Normal'
March 11, 2025
Via Benzinga
Topics Government
2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb
March 10, 2025
From 2seventy bio, Inc.
Via Business Wire
2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference
February 25, 2025
From 2seventy bio, Inc.
Via Business Wire
Novo Nordisk Eyes 2025 Regulatory Filing For Hemophilia Candidate After Encouraging Pediatric Study Data
February 07, 2025
Via Benzinga
2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results
February 06, 2025
From 2seventy bio, Inc.
Via Business Wire
2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress
November 12, 2024
From 2seventy bio, Inc.
Via Business Wire

Frequently Asked Questions

Is 2seventy bio, Inc. - Common Stock publicly traded?
Yes, 2seventy bio, Inc. - Common Stock is publicly traded.
What exchange does 2seventy bio, Inc. - Common Stock trade on?
2seventy bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for 2seventy bio, Inc. - Common Stock?
The ticker symbol for 2seventy bio, Inc. - Common Stock is TSVT on the Nasdaq Stock Market
What is the current price of 2seventy bio, Inc. - Common Stock?
The current price of 2seventy bio, Inc. - Common Stock is 5.000
When was 2seventy bio, Inc. - Common Stock last traded?
The last trade of 2seventy bio, Inc. - Common Stock was at 05/12/25 04:00 PM ET
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap